Erratum: International Reports of Unexpected Low Plasma Concentrations of Dabigatran Suggest That More Frequent Measurements Will Add Value

Ruth L Savage^{1

2

3}, Marilina Castellano¹, Michael V Tatley²

Affiliations

¹ WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre, Uppsala, Sweden.
² Department of Preventive and Social Medicine, New Zealand Pharmacovigilance Centre, University of Otago, Dunedin, New Zealand.
³ Department of General Practice, University of Otago, Christchurch, New Zealand.

Published Erratum

Ruth L Savage et al. Semin Thromb Hemost. 2017 Oct.

. 2017 Oct;43(7):806-808.

doi: 10.1055/s-0037-1606861. Epub 2017 Sep 12.

Ruth L Savage^{1

2

3}, Marilina Castellano¹, Michael V Tatley²

¹ WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre, Uppsala, Sweden.
² Department of Preventive and Social Medicine, New Zealand Pharmacovigilance Centre, University of Otago, Dunedin, New Zealand.
³ Department of General Practice, University of Otago, Christchurch, New Zealand.

No abstract available

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

International Reports of Unexpected Low Plasma Concentrations of Dabigatran Suggest That More Frequent Measurements Will Add Value.
Savage RL, Castellano M, Tatley MV. Savage RL, et al. Semin Thromb Hemost. 2017 Sep;43(6):635-638. doi: 10.1055/s-0037-1603361. Epub 2017 Jun 13. Semin Thromb Hemost. 2017. PMID: 28609795 No abstract available.